Kento Fukano

Statistics

Publications

Citations

496

H-Index

Active since

2016

Affiliations

National Institute of Infectious Diseases(Current)

Tokyo University of Science

Institut National de la Transfusion Sanguine

Japan Science and Technology Agency

National Center for Global Health and Medicine

Kento Fukano is an author at National Institute of Infectious Diseases specializing in viral hepatitis, molecular virology, and viral entry inhibitors.

ORCID

Publications per year

2016–2023

Publications

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity

Satomi Shimura, Koichi Watashi, Kento Fukano et al. · Journal of Hepatology · 2016 · 126 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

MCPIP1 reduces HBV-RNA by targeting its epsilon structure

Yingfang Li, Lusheng Que, Kento Fukano et al. · Scientific Reports · 2020 · 64 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry

Toby Passioura, Koichi Watashi, Kento Fukano et al. · Cell chemical biology · 2018 · 63 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes

Kento Fukano, Senko Tsukuda, Mizuki Oshima et al. · Frontiers in Microbiology · 2019 · 57 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity

Junko S. Takeuchi, Kento Fukano, Masashi Iwamoto et al. · Journal of Virology · 2018 · 33 citations · Full text

Life Sciences, Biology, Evolutionary Biology +17

1–5 of 13